Author Search Results for "Allen Loyd V Jr"

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Nov/Dec 2024 Pg. 452-453	Prescription - Dermatology and Wound Care Author(s): Allen Loyd V Jr
Nov/Dec 2024 Pg. 482	Benzoyl Peroxide 10% Gel Author(s): Allen Loyd V Jr
Nov/Dec 2024 Pg. 483	Cohen’s Rectal Ointment Author(s): Allen Loyd V Jr
Nov/Dec 2024 Pg. 484	Diaper Rash Cream with Miconazole Author(s): Allen Loyd V Jr
Nov/Dec 2024 Pg. 485	Emanuel Butt Paste Author(s): Allen Loyd V Jr
Nov/Dec 2024 Pg. 486	Lidocaine Hydrochloride 2% Viscous Oral Topical Solution Author(s): Allen Loyd V Jr
Nov/Dec 2024 Pg. 487	Riley Butt Cream Author(s): Allen Loyd V Jr
Nov/Dec 2024 Pg. 488	Sucralfate and Hyaluronic Acid Ointment Author(s): Allen Loyd V Jr
Nov/Dec 2024 Pg. 489	Tetracaine Hydrochloride 2% Topical Solution Author(s): Allen Loyd V Jr
Nov/Dec 2024 Pg. 490	Tetracaine 4% and Menthol 5% Topical Gel Author(s): Allen Loyd V Jr
Nov/Dec 2024 Pg. 491	Wound Gel Author(s): Allen Loyd V Jr
Sep/Oct 2024 Pg. 356	Prescription: Technology in Compounding Author(s): Allen Loyd V Jr
Sep/Oct 2024 Pg. 358-362	Pharmaceutical Waters Used in Sterile and Nonsterile Compounding Author(s): Allen Loyd V Jr
Sep/Oct 2024 Pg. 374-375	Standard Operating Procedure for Assignment of Beyond-Use Dates Author(s): Allen Loyd V Jr
Sep/Oct 2024 Pg. 376-381	Quality Control: Water Activity Considerations for Beyond-use Dates Author(s): Allen Loyd V Jr
Sep/Oct 2024 Pg. 396	Quetiapine Fumarate 40-mg/mL Nonaqueous Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2024 Pg. 397	Diclofenac Sodium 1% Soft-Patch Gel Author(s): Allen Loyd V Jr
Sep/Oct 2024 Pg. 398	Diclofenac Sodium 1% Soft-Patch Lipophilic Gel Author(s): Allen Loyd V Jr
Sep/Oct 2024 Pg. 399	Fluconazole 2% Topical Microemulsion Author(s): Allen Loyd V Jr
Sep/Oct 2024 Pg. 400	Lidocaine Hydrochloride 2% Viscous Oral Topical Solution Author(s): Allen Loyd V Jr
Sep/Oct 2024 Pg. 401	Piroxicam 1% Soft-Patch Lipophilic Gel Author(s): Allen Loyd V Jr
Jul/Aug 2024 Pg. 268-269	Prescription: Pediatric/Geriatric Author(s): Allen Loyd V Jr
Jul/Aug 2024 Pg. 296-297	Basics of Compounding: Tips and Hints, Part 4: Lollipops/Lozenges, Gummy Bears, Patches, Flavoring/Coloring, Sweeteners, and Packaging Author(s): Allen Loyd V Jr
Jul/Aug 2024 Pg. 298-303	Sterile Basics of Compounding: Repackaging, Part 1 Author(s): Allen Loyd V Jr
Jul/Aug 2024 Pg. 306	Cholestyramine 6.5% Ointment Author(s): Allen Loyd V Jr
Jul/Aug 2024 Pg. 307	Clozapine 20-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2024 Pg. 308	Gabapentin 5% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Jul/Aug 2024 Pg. 309	Ivermectin 0.8% Creme Rinse Author(s): Allen Loyd V Jr
Jul/Aug 2024 Pg. 310	Lidocaine HCl 4%-Epinephrine HCl 0.05%-Tetracaine HCl 0.5% Topical Gel Author(s): Allen Loyd V Jr
Jul/Aug 2024 Pg. 311	Milk of Magnesia Concentrate, Unﬂavored Author(s): Allen Loyd V Jr
Jul/Aug 2024 Pg. 312	Natural Head Lice Repellant Spray Author(s): Allen Loyd V Jr
Jul/Aug 2024 Pg. 313	Niacinamide 4% Acne Gel Author(s): Allen Loyd V Jr
Jul/Aug 2024 Pg. 314	Promethazine Hydrochloride 50 mg/mL in PLO Gel Author(s): Allen Loyd V Jr
Jul/Aug 2024 Pg. 315	Selegiline Hydrochloride 1-mg/0.05-mL Oral Suspension in Oil Author(s): Allen Loyd V Jr
May/Jun 2024 Pg. 180	Prescription: Veterinary Author(s): Allen Loyd V Jr
May/Jun 2024 Pg. 242	Amlodipine Besylate Veterinary Suspension Author(s): Allen Loyd V Jr
May/Jun 2024 Pg. 243	Carprofen 2.5-mg/mL Oral Suspension, Veterinary Author(s): Allen Loyd V Jr
May/Jun 2024 Pg. 244	Diltiazem 5% in Lipoderm, Veterinary Author(s): Allen Loyd V Jr
May/Jun 2024 Pg. 245	Miconazole 1% Ophthalmic Solution, Veterinary Author(s): Allen Loyd V Jr
Mar/Apr 2024 Pg. 92	Prescription: Compounding for Pain Management Patients Author(s): Allen Loyd V Jr
Mar/Apr 2024 Pg. 130	Amitriptyline 4%, Dextromethorphan Hydrobromide 20%, and Tramadol Hydrochloride 5% in Pluronic Lecithin Organogel GEL Author(s): Allen Loyd V Jr
Mar/Apr 2024 Pg. 131	Amitriptyline Hydrochloride 2%, Carbamazepine 2%, Gabapentin 10%, and Ketoprofen 2% Transdermal Gel Author(s): Allen Loyd V Jr
Mar/Apr 2024 Pg. 132	Analgesic Compound Lotion, Clear Author(s): Allen Loyd V Jr
Mar/Apr 2024 Pg. 133	Benzocaine 20%, Lidocaine 6%, and Tetracaine 4% in Lipoderm Author(s): Allen Loyd V Jr
Mar/Apr 2024 Pg. 134	Diclofenac Sodium 1% Soft-patch Gel Author(s): Allen Loyd V Jr
Mar/Apr 2024 Pg. 135	Ketamine Hydrochloride 5%, Gabapentin 10%, Clonidine Hydrochloride 0.2%, and Baclofen 2% in Lipoderm Author(s): Allen Loyd V Jr
Mar/Apr 2024 Pg. 136	Ketoprofen 10%, Baclofen 2%, Cyclobenzaprine Hydrochloride 2%, Lidocaine 2% in Lipopen Ultra Cream Base Author(s): Allen Loyd V Jr
Mar/Apr 2024 Pg. 137	Rectal Rockets: Lidocaine 3%, Hydrocortisone 2% Author(s): Allen Loyd V Jr
Jan/Feb 2024 Pg. 4	PreScription: IJPC is now all Digital Author(s): Allen Loyd V Jr
Jan/Feb 2024 Pg. 58	Estradiol 0.1% Vaginal Solution Author(s): Allen Loyd V Jr
Jan/Feb 2024 Pg. 59	Estradiol 1-mg/0.1-g Topical Cream Author(s): Allen Loyd V Jr
Jan/Feb 2024 Pg. 60	Estriol and Estradiol 1.25, 2.5, and 5 mg (BiEst) Capsules Author(s): Allen Loyd V Jr
Jan/Feb 2024 Pg. 61	Progesterone 10% Topical Cream Author(s): Allen Loyd V Jr
Jan/Feb 2024 Pg. 62	Progesterone 100-mg/mL Sublingual Drops Author(s): Allen Loyd V Jr
Jan/Feb 2024 Pg. 63	Progesterone Vaginal Suppositories (Fatty Acid Base) Author(s): Allen Loyd V Jr
Jan/Feb 2024 Pg. 64	Testosterone 1 mg/0.1 mL in a PLO Gel Author(s): Allen Loyd V Jr
Jan/Feb 2024 Pg. 65	Testosterone 2-mg and Dehydroepiandrosterone (DHEA) 15-mg Troches Author(s): Allen Loyd V Jr
Jan/Feb 2024 Pg. 66	Testosterone 10-mg/0.1-mL Sublingual Drops Author(s): Allen Loyd V Jr
Jan/Feb 2024 Pg. 67	Triple Estrogen 2.5 mg Tablet Triturates Author(s): Allen Loyd V Jr
Nov/Dec 2023 Pg. 444	PreScription: Changes Are Coming! Author(s): Allen Loyd V Jr
Nov/Dec 2023 Pg. 474-481	Nonsterile Basics of Compounding: Using U.S. Food and Drug Administration-approved Commercial Products as Ingredients Author(s): Allen Loyd V Jr
Nov/Dec 2023 Pg. 483-486	Sterile Basics of Compounding: Allowable Endotoxin Levels in Parenteral Preparations Author(s): Allen Loyd V Jr
Nov/Dec 2023 Pg. 490	Curcumin 1% Intranasal Mucoadhesive Gel Author(s): Allen Loyd V Jr
Nov/Dec 2023 Pg. 491	Hyaluronidase Injection Author(s): Allen Loyd V Jr
Nov/Dec 2023 Pg. 492	Hydrocortisone 2% and Menthol 0.5% in VersaPro Cream Base Author(s): Allen Loyd V Jr
Nov/Dec 2023 Pg. 493	Salicylic Acid 30% Gel Author(s): Allen Loyd V Jr
Sep/Oct 2023 Pg. 356	PreScription: Data Security/Breaches: What is the Effect on Pharmacies? Author(s): Allen Loyd V Jr
Sep/Oct 2023 Pg. 382-385	Excipients and Adverse Events Author(s): Allen Loyd V Jr
Sep/Oct 2023 Pg. 386-395	Basics of Compounding: Compounding Foams Author(s): Allen Loyd V Jr
Sep/Oct 2023 Pg. 397-409	Basics of Sterile Compounding: Sterile Basics of Compounding Intravenous Admixtures, Part 4: Physicochemical Considerations Author(s): Allen Loyd V Jr
Sep/Oct 2023 Pg. 412	Crotamiton 10% Cream Author(s): Allen Loyd V Jr
Sep/Oct 2023 Pg. 414-415	Fluconazole 1% Thermoresponsive Gel Author(s): Allen Loyd V Jr
Sep/Oct 2023 Pg. 416	Hydrocortisone 2% in Versapro Cream Author(s): Allen Loyd V Jr
Sep/Oct 2023 Pg. 417	Idoxuridine 5% in Dimethyl Sulfoxide Author(s): Allen Loyd V Jr
Sep/Oct 2023 Pg. 418-419	Ipratropium Bromide 0.05% Nasal Spray Author(s): Allen Loyd V Jr
Sep/Oct 2023 Pg. 420	Nitazoxanide 20-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2023 Pg. 421	Povidone Iodine Lotion Author(s): Allen Loyd V Jr
Sep/Oct 2023 Pg. 422-423	Silver Sulfadiazine 1% and Hydrocortisone 2% Gel Author(s): Allen Loyd V Jr
Jul/Aug 2023 Pg. 268	PreScription: Our Lives Are Shaped by the Decisions We Make! Author(s): Allen Loyd V Jr
Jul/Aug 2023 Pg. 295-302	Nonsterile Basics of Compounding: Compounding with Antioxidants, Part 1: An Overview Author(s): Allen Loyd V Jr
Jul/Aug 2023 Pg. 305-313	Sterile Basics of Compounding: Intravenous Admixture Compounding, Part 3: Preparation Procedures Author(s): Allen Loyd V Jr
Jul/Aug 2023 Pg. 316	Chlorhexidine and Cetrimide Lotion Author(s): Allen Loyd V Jr
Jul/Aug 2023 Pg. 317-318	Clobazam 5-mg/mL Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2023 Pg. 319	Clotrimazole 1% and Betamethasone Dipropionate 0.05% Cream Author(s): Allen Loyd V Jr
Jul/Aug 2023 Pg. 320-321	Cyclosporine Topical Gel Formulation Author(s): Allen Loyd V Jr
Jul/Aug 2023 Pg. 322	Dexamethasone 1 mg/mL in Oral Mix SF Author(s): Allen Loyd V Jr
Jul/Aug 2023 Pg. 323	Lamotrigine 1 mg/mL in SuspendIt Plus Author(s): Allen Loyd V Jr
Jul/Aug 2023 Pg. 324-325	Levofloxacin 0.5% Topical Gel Author(s): Allen Loyd V Jr
Jul/Aug 2023 Pg. 326	Losartan Potassium 2.5-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jul/Aug 2023 Pg. 327	Nystatin Oromucosal Gel Author(s): Allen Loyd V Jr
Jul/Aug 2023 Pg. 328	Rifampin 10-mg/mL Nasal Drops Author(s): Allen Loyd V Jr
Jul/Aug 2023 Pg. 329	Trihexyphenidyl Hydrochloride 1-mg/mL Oral Liquid, Alcohol-free Author(s): Allen Loyd V Jr
May/Jun 2023 Pg. 180	PreScription: Shortages Continue--Compounding Pharmacies Fill the Gap…Again! Author(s): Allen Loyd V Jr
May/Jun 2023 Pg. 218-221	Nonsterile Basics of Compounding: Compounding with Humectants Author(s): Allen Loyd V Jr
May/Jun 2023 Pg. 223-229	Sterile Basics: Intravenous Admixture Compounding, Part 2: Parenteral Vehicle Considerations Author(s): Allen Loyd V Jr
May/Jun 2023 Pg. 232-233	Acetaminophen 500-mg/mL Rectal Solution Author(s): Allen Loyd V Jr
May/Jun 2023 Pg. 234	Doxycycline 166.7-mg/mL Oral Suspension (Veterinary) Author(s): Allen Loyd V Jr
May/Jun 2023 Pg. 235	Gentamicin 480-mg/1000-mL Bladder Irrigation Author(s): Allen Loyd V Jr
May/Jun 2023 Pg. 236	Methylene Blue 5-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2023 Pg. 237	Migraine Headache Suppositories Author(s): Allen Loyd V Jr
May/Jun 2023 Pg. 238	Nifedipine, Lidocaine, and Nitroglycerin Suppositories Author(s): Allen Loyd V Jr
May/Jun 2023 Pg. 239	Nystatin Oromucosal Viscous Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2023 Pg. 92	PreScription: Amoxicillin Shortage Continues: Compounding Pharmacies Filling the Gap! Author(s): Allen Loyd V Jr
Mar/Apr 2023 Pg. 123-139	Sterile Basics: Intravenous Admixture Compounding, Part 1: Introduction and Overview of the General Guidelines for an Intravenous Admixture Compounding Program, and Compounding Personnel Considerations Author(s): Allen Loyd V Jr
Mar/Apr 2023 Pg. 142	Aminohippurate Sodium 250 mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2023 Pg. 143	Amphotericin B 0.1% Topical Microemulsion Author(s): Allen Loyd V Jr
Mar/Apr 2023 Pg. 144	Aphthous Ulcer Gel Author(s): Allen Loyd V Jr
Mar/Apr 2023 Pg. 145	Bethanechol 0.01% in Lanolin 10% and White Petrolatum 90% Author(s): Allen Loyd V Jr
Mar/Apr 2023 Pg. 146	Cyclosporine Topical Microemulsion Author(s): Allen Loyd V Jr
Mar/Apr 2023 Pg. 147	Hypochlorous Acid 0.01% Oral Rinse Author(s): Allen Loyd V Jr
Mar/Apr 2023 Pg. 148	Nystatin, Lidocaine, Hydrocortisone, and Chlorhexidine Oral Rinse Author(s): Allen Loyd V Jr
Mar/Apr 2023 Pg. 149-151	Pilocarpine Hydrochloride 0.3% w/v Solution Author(s): Allen Loyd V Jr
Mar/Apr 2023 Pg. 152	Sacrosidase 8,500 Units Per mL Oral Solution Author(s): Allen Loyd V Jr
Mar/Apr 2023 Pg. 153	Timolol 0.125%/Mucolox 15%/0.9% Normal Saline Nasal Spray Author(s): Allen Loyd V Jr
Jan/Feb 2023 Pg. 4	PreScription: New Drug Approvals 2022 and Compounding Opportunities Author(s): Allen Loyd V Jr
Jan/Feb 2023 Pg. 30-37	Advanced Compounding: Compounding with Microneedle Arrays, Part 3: Microneedle Array Development in the Literature and Quality Control of Microneedle Arrays Author(s): Allen Loyd V Jr
Jan/Feb 2023 Pg. 50	Acetaminophen 10 mg/mL for Rectal Use Author(s): Allen Loyd V Jr
Jan/Feb 2023 Pg. 51	Clozapine 20 mg/mL in Ora-Sweet and Ora-Plus Author(s): Allen Loyd V Jr
Jan/Feb 2023 Pg. 52	Dapsone 2 mg/mL in Ora-Sweet and Ora-Plus Author(s): Allen Loyd V Jr
Jan/Feb 2023 Pg. 53	Erlotinib 10 mg/mL in Ora-Sweet and Ora-Plus Author(s): Allen Loyd V Jr
Jan/Feb 2023 Pg. 54	Manning's Liniment Author(s): Allen Loyd V Jr
Jan/Feb 2023 Pg. 55	Mayer's Ointment Author(s): Allen Loyd V Jr
Jan/Feb 2023 Pg. 56	Povidone Iodine 100-mg/mL Solution/Spray Author(s): Allen Loyd V Jr
Jan/Feb 2023 Pg. 57	Psoriasis Topical Ointment Author(s): Allen Loyd V Jr
Jan/Feb 2023 Pg. 58-59	Suspension Solution, Sugar Free Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 444	PreScription: Compounded Drugs Often Become Manufactured Drugs Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 446-466	Compounding with Biotechnology Products, Part 2: Product-specific Considerations Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 490-495	Compounding with Microneedle Arrays, Part 2: Preparation and Administration Methods Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 508	Bacitracin 0.01% and Phenol 0.1% in Cetaphil Lotion Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 509	Curcumin 2% Topical Gel Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 510	Diazoxide 10-mg/mL in Oral Mix SF Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 511	Enrofloxacin 11.35 mg/mL in Ora-Blend, Veterinary Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 512	Flucytosine 50 mg/mL in Oral-Sweet and Ora-Plus Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 513	Granisetron Hydrochloride 005 mg/mL in Ora-Sweet and Ora-Plus Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 514	Miller's Modified Mouthwash Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 515	Potassium Alum 1% Bladder Irrigation for Hemorrhagic Cystitis (Low-Medium Risk Compounding) Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 356	PreScription: A New Dosage Form Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 385-395	Compounding with Biotechnology Products, Part 1: General Considerations Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 400-408	Basics of Compounding: Compounding with Microneedle Arrays, Part 1: Introduction and Overview Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 422	Amphotericin B 3% Otic Gel Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 423	Ascorbic acid 5% Topical Microemulsion Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 424	Chlorhexidine Diacetate 2% Topical Gel Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 425	Clindamycin Hydrochloride 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 426	Clotrimazole 10-mg Troches Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 427	Cysteamine Hydrochloride 100 mg/mL Oral Solution Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 428	Hydrogen Peroxide 1.5% with Sodium Fluoride 0.5-mg/mL Oral Rinse Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 429	Lansoprazole 3-mg/mL in Ora-Blend Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 430	Metronidazole 10%, Nifedipine 0.5%, Lidocaine 1.5%, and Diclofenac 3% Ointment Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 431	Methylcobalamin 2-mg/mL Nasal Spray Author(s): Allen Loyd V Jr
Jul/Aug 2022 Pg. 268	PreScription: Pharmacy and Drug Information Author(s): Allen Loyd V Jr
Jul/Aug 2022 Pg. 302-307	Basics: Hollow-type Suppositories Author(s): Allen Loyd V Jr
Jul/Aug 2022 Pg. 318	Betamethasone Dipropionate 0.05% and Salicylic Acid 3% Lotion Author(s): Allen Loyd V Jr
Jul/Aug 2022 Pg. 319	Cetrimide Lotion Author(s): Allen Loyd V Jr
Jul/Aug 2022 Pg. 320	Dexamethasone 1 mg/mL in Oral Mix Author(s): Allen Loyd V Jr
Jul/Aug 2022 Pg. 321-322	Furosemide 5-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2022 Pg. 323-324	Hydralazine Hydrochloride 10 mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jul/Aug 2022 Pg. 325-326	Indomethacin 1% Topical Gel Author(s): Allen Loyd V Jr
Jul/Aug 2022 Pg. 327	Nystatin 250,000-unit Frozen Popsicles Author(s): Allen Loyd V Jr
Jul/Aug 2022 Pg. 328	Povidone Iodine 100-mg/mL Solution/Spray Author(s): Allen Loyd V Jr
Jul/Aug 2022 Pg. 329	Psoriasis Topical Ointment Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 180	PreScription: Standing in the Gap Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 201-209	Compounding for Investigational and Clinical Studies Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 214-217	Basics of Compounding: Vehicle for Drug Administration via Enteral Feeding Tubes Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 219-228	Sterile Basics of Compounding: Particulates in Parenteral Preparations: Sources, Minimization, and Detection Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 232	Alendronate Sodium 1% Topical Dental Gel Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 233	Azstarys in Ora-Blend Single Dose Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 234	Candesartan Cilexitil 1 mg/mL Syrup Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 235	Chloral Hydrate 70 mg/mL Syrup Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 236	Cinnarizine 1 mg/mL in Oral Medium-Chain Triglycerides Anhydrous Vehicle Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 237	Clobazam 1 mg/mL in Oral-Mix Suspension Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 238	Metronidazole 7.5 mg/mL Topical Oil-in-Water Microemulsion Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 239	Nitrazepam 1 mg/mL Oral Solution Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 240	Sirolimus 0.1% Ointment Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 241	Valganciclovir 20 mg/mL in Ora-Plus and Ora-Sweet Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 92	PreScription: Comments on the FDA Guidance "Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act: Guidance for Industry" Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 116-117	Quality Control: Photodocumentation in Pharmacy Compounding Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 118-126	Basics of Compounding: Compounding Nonsterile Preparations Using Cyclodextrins Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 129-136	Sterile Basics of Compounding: Methods of Sterilization and Depyrogenation Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 140	Alprazolam 1 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 141	Codeine Phosphate 3 mg/mL in Ora-Sweet Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 142	Ketoconazole 2%, Terbenafine 1%, Acetic Acid 2%, and Urea 2% in Dimethyl Sulfoxide Nail Polish Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 143	Lorazepam 1 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 144	Mesalamine 100-mg/mL Suspension Enema Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 145	Naproxen 25 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 146	Phenobarbital 10 mg/mL in SyrSpend SF pH4, Cherry Flavored Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 147	Phenytoin 15 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 148	Propranolol 2 mg/mL and 5 mg/mL in Ora-Blend SF Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 149	Pyridoxine Hydrochloride 50 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Jan/Feb 2022 Pg. 4	PreScription: IJPC--Starting Year 26 Author(s): Allen Loyd V Jr
Jan/Feb 2022 Pg. 24-28	Editorial: Should All Pharmacists Compound? Author(s): Allen Loyd V Jr
Jan/Feb 2022 Pg. 34-38	Basics: Considerations and Background Information for Counseling Patients Using Compounded Suppositories Author(s): Allen Loyd V Jr
Jan/Feb 2022 Pg. 41-49	Sterile Basics: Compounding Sterile Preparations with Cyclodextrins Author(s): Allen Loyd V Jr
Jan/Feb 2022 Pg. 52	Aluminum Chloride 6.25% in Anhydrous Alcohol Author(s): Allen Loyd V Jr
Jan/Feb 2022 Pg. 53	Ascorbic Acid 10% in Anhydrous PEG ointment Author(s): Allen Loyd V Jr
Jan/Feb 2022 Pg. 54	Deoxyarbutin 3% Anhydrous Emulsion Author(s): Allen Loyd V Jr
Jan/Feb 2022 Pg. 55	Diclofenac Sodium 1%-15% Topical Gel Author(s): Allen Loyd V Jr
Jan/Feb 2022 Pg. 56	Enalapril Maleate 1 mg-mL in Ora-Plus and Ora-Sweet Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2022 Pg. 57	Mometasone Furoate 0.1% Lotion Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 444	PreScription: IJPC -- Twenty-Five Year Anniversary Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 486-489	Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 12: Sorbents (Adsorbents and Absorbents) Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 491-496	Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 12: United States Pharmacopeia Chapters Referenced in the Current United States Pharmacopeia Chapter <797> Pharmaceutical Compounding -- Sterile Preparations Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 500	Domperidone 5 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 501	Kayexalate in Lactulose Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 502	Levetiracetam 50 mg/mL in Ora-Sweet and Ora-Plus Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 503	Metoprolol Tartrate 10 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 504	Propranolol 2 mg/mL or 5 mg/mL in Ora-Sweet Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 505	Pyridoxine Hydrochloride 25 mg/mL in Oral Mix and Oral Mix SF Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 506	Quetiapine Fumarate 10 mg/mL in Ora-Blend Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 507	Shari's Burn Cream Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 508	Sulfadiazine 100 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 509	Ziprasidone Mesylate 2.5 mg/mL in Ora-Sweet Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 356	PreScription: Permissible Exposure Limits and United States Pharmacopeia Chapter <800> Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 396-400	Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 11: Drug Tastes: Innate, Induced, and Improved Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 403-408	Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 11: Particulate Issues --- Silicone Oil in Vials, Cartridges, and Syringes Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 412	Atropine Sulfate 0.1 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 413	Cilazapril 1-mg/mL in Ora-Blend Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 414	Clonidine 0.01-mg/mL in Ora-Blend Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 415	Dapsone 2-mg/mL in Oral Mix or Oral Mix SF Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 416	Dexamethasone 1-mg/mL in Oral Mix or Oral Mix SF Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 417	Haloperidol 0.5-mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 418	Imipramine Hydrochloride 5-mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 419	Mycophenolate Mofetil 50-mg/mL in Ora-Plus:Cherry Syrup Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 420	Sorafenib 20-mg/mL in Oil Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 421	Spironolactone 2-mg/mL or 2-5.mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 268	PreScription: Endemics, Epidemics, and Pandemics Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 304-309	Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 10: Rectal Suppository Bases Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 311-317	Basics of Sterile Compounding: Intravenous Admixture Preparation Considerations, Part 10: Packaging and Container-closure Issues Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 320	Apixaban 0.25-mg/mL Suspension for Enteral Feeding Tube Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 321	Atomoxetine 4-mg/mL Oral Solution/Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 322	BHR in PLO Gel (Benadryl, Haldol, and Reglan in Pluronic Lecithin Organogel) Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 323	Budesonide 0.0.25% Mucoadhesive Gel Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 324	Cyclopentolate Hydrochloride 0.5%, Phenylephrine HCl 2.5%, and Tropicamide 0.5% Ophthalmic Solution Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 325	Hydrocortisone 2-mg/mL in Oral Mix Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 326	Moh's Paste, Modified Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 327	Nifedipine 4.mg/mL in SyrSpend SF pH4 Cherry Flavored Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 328	Tacrolimus 0.1% Topical Microemulsion Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 329	Valsartan 4-mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
May/Jun 2021 Pg. 180	PreScription: The Ethical Pharmacist Author(s): Allen Loyd V Jr
May/Jun 2021 Pg. 218-221	Basics of Compounding: Excipients Used in Nonsterile Compounding: Diluents Author(s): Allen Loyd V Jr
May/Jun 2021 Pg. 222-229	Intravenous Admixture Preparation Considerations, Part 9-B: Error Prevention in Intravenous Admixture Preparation Author(s): Allen Loyd V Jr
May/Jun 2021 Pg. 232	Levofloxacin 50-mg/mL in Ora-Plus and Strawberry Syrup Suspension Author(s): Allen Loyd V Jr
May/Jun 2021 Pg. 233	Naltrexone Hydrochloride 0.5 mg/mL and 5.0 mg/mL in SuspendIt Suspension Author(s): Allen Loyd V Jr
May/Jun 2021 Pg. 234	Tacrolimus 0.5 mg/mL in Ora-Plus and Simple Syrup Suspension Author(s): Allen Loyd V Jr
May/Jun 2021 Pg. 235	Temozolomide 10 mg/mL in Oral Mix SF Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2021 Pg. 92	PreScription: The Past (-->2020), The Present, and The Future (2021-->) Author(s): Allen Loyd V Jr
Mar/Apr 2021 Pg. 126-128	Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 8: Humectants Author(s): Allen Loyd V Jr
Mar/Apr 2021 Pg. 131-139	Intravenous Admixture Preparation Considerations, Part 9-A: Error Prevention in Intravenous Admixture Preparation Author(s): Allen Loyd V Jr
Mar/Apr 2021 Pg. 142	Amlodipine 1-mg/mL in Oral Mix Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2021 Pg. 143	Canine Soft Chew Base (Veterinary) Author(s): Allen Loyd V Jr
Mar/Apr 2021 Pg. 144	Eslicarbazepine Acetate 40-mg/mL in Ora-Plus with Ora-Sweet or Ora-Sweet SF Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2021 Pg. 145	Levodopa/Carbidopa 5.0/1.25 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Jan/Feb 2021 Pg. 4	PreScription: The NASEM cBHT Report, Part 2 Author(s): Allen Loyd V Jr
Jan/Feb 2021 Pg. 31-38	Intravenous Admixture Preparation Considerations, Part 8: Ready-to-Use Preparations Author(s): Allen Loyd V Jr
Jan/Feb 2021 Pg. 42	Acetaminophen (Paracetamol) 50 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Jan/Feb 2021 Pg. 43	Amlodipine Besylate 0.5-mg/mL to 10-mg/mL in SuspendIt Oral Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2021 Pg. 44	Clonidine 0.01-mg/mL in Oral Mix and Oral Mix SF Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2021 Pg. 45	Cyclophosphamide 10 mg/mL in Oral-Plus or Simple Syrup Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2021 Pg. 46	Diclofenac Sodium 5 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Jan/Feb 2021 Pg. 47	Metronidazole 50-mg/mL in Oral Mix and Oral Mix SF Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2020 Pg. 444	PreScription: The NASEM cBHT Report, Part 1 Author(s): Allen Loyd V Jr
Nov/Dec 2020 Pg. 446-448	NASEM Report on Compounded Topical Pain Creams Author(s): Allen Loyd V Jr
Nov/Dec 2020 Pg. 473-478	Intravenous Admixture Preparation Considerations, Part 7: Stability Issues Author(s): Allen Loyd V Jr
Sep/Oct 2020 Pg. 356	Safety and Efficacy Studies, Pharmacy Education, and the NASEM Report on Compounded Topical Pain Creams Author(s): Allen Loyd V Jr
Sep/Oct 2020 Pg. 388-395	Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 7: Compounding with Surfactants Author(s): Allen Loyd V Jr
Sep/Oct 2020 Pg. 397-402	Intravenous Admixture Preparation Considerations, Part 6: pH Considerations -- Applications Author(s): Allen Loyd V Jr
Sep/Oct 2020 Pg. 406	Ketamine 60.6-mg/mL, Acepromazine 0.6-mg/mL, and Xylazine 6.67-mg/mL Injection (Vet-Rat and Hamster); Ketamine 6.06-mg/mL, Acepromazine 0.06-mg/mL, and Xylazine 0.667-mg/mL Injection (Vet-Mouse) Author(s): Allen Loyd V Jr
Sep/Oct 2020 Pg. 407	Levofloxacin 50 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2020 Pg. 268	PreScription: COVID-19 and Compounding Pharmacists Author(s): Allen Loyd V Jr
Jul/Aug 2020 Pg. 305-309	Sterile Basics: Intravenous Admixture Preparation Considerations, Part 5: pH Considerations Author(s): Allen Loyd V Jr
Jul/Aug 2020 Pg. 312	Benzonatate 50 mg/mL in Ora-Sweet Author(s): Allen Loyd V Jr
Jul/Aug 2020 Pg. 313	Cyclobenzaprine 5-mg/g and Guaifenesin 10-mg/g Transdermal Cream Author(s): Allen Loyd V Jr
Jul/Aug 2020 Pg. 314	Doxepin Hydrochloride 5% in Cetaphil Cream Author(s): Allen Loyd V Jr
Jul/Aug 2020 Pg. 315	Hydrocortisone Hemisuccinate 2 mg/mL or Hydrocortisone Sodium Phosphate 2 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Jul/Aug 2020 Pg. 316	Hydroxychloroquine Sulfate 25 mg/mL in Ora-Plus:Ora-Sweet SF Author(s): Allen Loyd V Jr
Jul/Aug 2020 Pg. 317	Hydroxyzine (Pamoate) 25-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2020 Pg. 318	Lisinopril 1 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Jul/Aug 2020 Pg. 319	Lorazepam 1 mg/mL in a Nonaqueous Cosolvent Vehicle Author(s): Allen Loyd V Jr
Jul/Aug 2020 Pg. 320	Sumatriptan, Lidocaine Hydrochloride, Dexamethasone, Pentoxifylline, and Ibuprofen Transdermal Cream (Migraine Cream) Author(s): Allen Loyd V Jr
Jul/Aug 2020 Pg. 321	Tramadol Hydrochloride 10 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
May/Jun 2020 Pg. 180	PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>, <797>, and <825>: Part 2 Author(s): Allen Loyd V Jr
May/Jun 2020 Pg. 200-205	Quality Control: Photostability of Compounded Preparations Author(s): Allen Loyd V Jr
May/Jun 2020 Pg. 206-212	Basics: Excipients Used in Nonsterile Compounding, Part 6: Compounding with Viscosity-increasing Agents Author(s): Allen Loyd V Jr
May/Jun 2020 Pg. 215-220	Sterile Basics: Intravenous Admixture Preparation Considerations, Part 4: Particulates Author(s): Allen Loyd V Jr
May/Jun 2020 Pg. 224	Baclofen 10 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
May/Jun 2020 Pg. 225	Dexamethasone 1 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
May/Jun 2020 Pg. 226	Diphenylcyclopropenone 0.1% or 3% in Isopropranol Author(s): Allen Loyd V Jr
May/Jun 2020 Pg. 227	Ibuprofen 400-mg and Cyclobenzaprine 2.5-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2020 Pg. 228	Monsel's Solution, Gel, and Paste Author(s): Allen Loyd V Jr
May/Jun 2020 Pg. 229	Prednisolone 1 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
May/Jun 2020 Pg. 230	Sildenafil 2.5 mg/mL in Methylcellulose 1%:Syrup (1:1) Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2020 Pg. 231	Tetracycline Hydrochloride 25 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
May/Jun 2020 Pg. 232	Ursodiol 100 mg/mL in Cod Liver Oil, Veterinary Author(s): Allen Loyd V Jr
May/Jun 2020 Pg. 233	Venlafaxine 15 mg/mL in Ora-Plus:Ora-Sweet (1:1) Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 92	PreScription: Formal Appeals to United States Pharmacopeia Regarding USP Chapters <795>,<797>, and <825>: Part 1 Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 114-118	Basics of Nonsterile Compounding: Excipients Used in Nonsterile Compounding, Part 5: Compounding Using Solvents and Cosolvent Systems Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 121-126	Intravenous Admixture Preparation Considerations, Part 3: Methods and Techniques to Decrease Incompatibilities Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 130	Acetazolamide 25 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 131	Cholecalciferol 50,000 IU/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 132	Glycopyrrolate 0.2 mg/mL in Ora-Plus:Ora-Sweet (1:1) Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 133	Minocycline Hydrochloride 10 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 134	Nitrofurantoin 2 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 135	Propylthiouracil 5 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 136	Quinidine Sulfate 10 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 137	Terbinafine 25 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 138	Topiramate 5 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 139	Valsartan 4 mg/mL in Syrup NF Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 4	PreScription: One Size Does Not Fit All! Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 38-43	Basics: Excipients Used in Nonsterile Compounding, Part 4: Antioxidants and Chelating Agents Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 44-50	Intravenous Admixture Preparation Considerations, Part 2: Incompatibilities and Factors Involved Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 54	Amiodarone Hydrochloride 5 mg/mL in SyrSpend SF pH4 Cherry Flavored Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 55	Glutamine 250 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 56	Glycopyrrolate 0.2 mg/mL in Methylcellulose 1% and Syrup Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 57	Hydrocortisone 2%, Iodoquinol 1% Metronidazole 10%, and Zinc Oxide 2% in Polyethylene Glycol Ointment Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 58	Isoniazid 10 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 59	LCD 5%, Salicylic Acid 6% in Clobetasol Propionate 0.05% Ointment Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 60	Ondansetron Hydrochloride 0.8 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 61	Potassium Chloride 1 mmol/mL in Ora-Sweet SF Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 62	Progesterone 100-mg, Melatonin 1-mg, and L-Theanine 200-mg Slow-Release Capsules Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 63	Venlafaxine 15 mg/mL in Syrup Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 444	PreScription: As Things Change…. Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 472-477	Basics: Excipients Used in Nonsterile Compounding, Part 3: Preservatives Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 478-482	Intravenous Admixture Preparation Considerations, Part 1: Overview of Series on Personnel Selection for Intravenous Admixture Compounding Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 486	Gabapentin 50-mg/mL in SyrSpend SF Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 487	Prednisolone Sodium Phosphate 1.4 mg/mL in SyrSpend SR pH4, Cherry Flavored Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 488	Pregabaline 20 mg/mL in SyrSpend SR pH4 Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 489	Riboflavin 10 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 490	Sulfasalazine 100 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 491	Tacrolimus Monohydrate 1 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 492	Tadalafil 5 mg/mL in Oral-Plus:Ora-Sweet (1:1) Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 493	Ursodiol 30 mg/mL in SyrSpend SF Cherry Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 494	Verapmail Hydrochloride 50 mg/mL in SyrSpend SF Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 495	Zonisamide 10 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Sep/Oct 2019 Pg. 356	PreScription: Regulations, Laws, Standards, Guidelines, Procedures, Etc Author(s): Allen Loyd V Jr
Sep/Oct 2019 Pg. 393-396	Basics: Excipients Used in Nonsterile Compounding, Part 2 Author(s): Allen Loyd V Jr
Sep/Oct 2019 Pg. 399-402	Sterile Basics: Pharmaceutical Waters Used in Sterile and Nonsterile Compounding Author(s): Allen Loyd V Jr
Sep/Oct 2019 Pg. 406	Allopurinol 20 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Sep/Oct 2019 Pg. 407	Amitriptyline Hydrochloride 10 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Sep/Oct 2019 Pg. 408	Dipyridamole 10 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Sep/Oct 2019 Pg. 409	Omeprazole 2 mg/mL in SyrSpend SF Alka (Reconstituted) Author(s): Allen Loyd V Jr
Sep/Oct 2019 Pg. 410	Oxandrolone 3 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2019 Pg. 411	Sorafenib Capsules for Pediatric Use Author(s): Allen Loyd V Jr
Sep/Oct 2019 Pg. 412	Valsartan 4 mg/mL in Vehicle for Oral Solution USP Author(s): Allen Loyd V Jr
Sep/Oct 2019 Pg. 413	Verapamil Hydrochloride 50 mg/mL in Ora-Plus:Ora-Sweet (1:1) Author(s): Allen Loyd V Jr
Jul/Aug 2019 Pg. 268	PreScription: Temperatures by Degrees Author(s): Allen Loyd V Jr
Jul/Aug 2019 Pg. 299-303	Summary of Quality-Control Testing for Sterile and Nonsterile Compounded Preparations, Part 2: Microbiological Testing Author(s): Allen Loyd V Jr
Jul/Aug 2019 Pg. 305-311	Basics: Excipients Used in Nonsterile Compounding, Part 1 Author(s): Allen Loyd V Jr
Jul/Aug 2019 Pg. 314	Aripiprazole 1 mg/mL in Oral-Plus:Ora-Sweet (1:1) Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2019 Pg. 315	Candesartan Cilexetil 1 mg/mL in Syrup NF or Vehicle for Oral Solution USP Author(s): Allen Loyd V Jr
Jul/Aug 2019 Pg. 316	Domperidone 5 mg/mL in Oral Mix Author(s): Allen Loyd V Jr
Jul/Aug 2019 Pg. 317	Lorazepam 1 mg/mL in Anhydrous Organic Solvent System Author(s): Allen Loyd V Jr
Jul/Aug 2019 Pg. 318	Morphine Sulfate 0.2-mg/mL Solution Stored in Amber Oral Plastic Syringes Author(s): Allen Loyd V Jr
Jul/Aug 2019 Pg. 319	Rifampin 25 mg/mL in SyrSpend SF Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2019 Pg. 180	PreScription: Honesty/Ethics in Professions: The Gallup Polls Author(s): Allen Loyd V Jr
May/Jun 2019 Pg. 211-216	Summary of Quality-Control Testing for Sterile and Nonsterile Compounded Preparations, Part 1: Physical and Chemical Testing Author(s): Allen Loyd V Jr
May/Jun 2019 Pg. 221-228	Basics of Sterile Compounding: Vehicles Used in Sterile Compounding Author(s): Allen Loyd V Jr
May/Jun 2019 Pg. 230	Aripiprazole 1 mg/mL in Methylcellulose 1% Syrup Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2019 Pg. 231	Chloroquine Phosphate 15 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
May/Jun 2019 Pg. 232	Clopidogrel 5 mg/mL in a Sugar-Free Syrup Author(s): Allen Loyd V Jr
May/Jun 2019 Pg. 233	Flunisolide Nasal Spray Author(s): Allen Loyd V Jr
May/Jun 2019 Pg. 234	Mebeverine Hydrochloride 10 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
May/Jun 2019 Pg. 235	Methotrexate 2-mg/mL Oral Solution Author(s): Allen Loyd V Jr
May/Jun 2019 Pg. 236	Sildenafil 2.5 mg/mL in Ora-Plus:Ora-Sweet Author(s): Allen Loyd V Jr
May/Jun 2019 Pg. 237	Valsartan 16-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2019 Pg. 92	PreScription: Compounding with Cannabidiol Author(s): Allen Loyd V Jr
Mar/Apr 2019 Pg. 123-130	Basics of Compounding for Sterile, Nonsterile, and Quality Control Compounding: Process Analytical Technology: Appropriate for Sterile and Nonsterile Compounding? Author(s): Allen Loyd V Jr
Mar/Apr 2019 Pg. 135-143	Basics of Compounding: Summary of the Official United States Pharmacopeia Monographs for Compounded Preparations Author(s): Allen Loyd V Jr
Mar/Apr 2019 Pg. 146	Acetaminophen 50% Pluronic Lecithin Organogel Gel Author(s): Allen Loyd V Jr
Mar/Apr 2019 Pg. 147	Amlodipine 1 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2019 Pg. 148	Captopril 0.8 mg/mL in SyrSpend SF Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2019 Pg. 149	Dexamethasone 2 mg/g Topical Paste, Veterinary Author(s): Allen Loyd V Jr
Mar/Apr 2019 Pg. 150	Ketoprofen 10% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Mar/Apr 2019 Pg. 151	Perphenazine 0.5 mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Mar/Apr 2019 Pg. 152	Rosuvastatin 20-mg/5-mL Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2019 Pg. 153	Tacrolimus 0.5 mg/mL in Oral Mix Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 4	PreScription: The Cost of Information Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 35-44	Basics of Compounding: Standardization of Compounded Medications Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 52	Ketoprofen 10% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 53	Ketoprofen 20-mg/mL in SyrSPend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 54	Lidocaine Hydrochloride, Diphenhydramine Hydrochloride, Aluminum Hydroxide–Magnesium Hydrochloride–Simethicone Mouthwashes Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 55	Magnesium Sulfate and Lidocaine Hydrochloride Injection in Prefilled Syringes Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 56	Methimazole 5 mg/0.1 mL in Pluronic Lecithin Organogel Gel, Veterinary Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 57	Minoxidil 1-mg/mL in Ora-Plus and Ora-Sweet SF Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 58	Omeprazole 1 mg/mL and 4 mg/mL in Humco Flavor Sweet Sugar-Free Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 59	Orodispersible Film Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 60	Piperacillin 10 mg/mL in 0.9% Sodium Chloride Bladder Irrigation Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 61	Thiamine Hydrochloride 100 mg/mL in SurSPend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2018 Pg. 444	PreScription: Standardized Concentrations: Pro or Con? Author(s): Allen Loyd V Jr
Nov/Dec 2018 Pg. 492	Clonazepam 0.2 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2018 Pg. 493	Diltiazem Hydrochloride 12 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2018 Pg. 494	Enalapril Maleate 1 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2018 Pg. 495	Hydrocortisone 2 mg/mL in Inorpha Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2018 Pg. 496	Hydroxyurea 100 mg/mL in Ora-Plus:Ora-Sweet, Ora-Plus: Ora-Sweet SF, Ora-Blend or Oral-Blend SF Oral Suspensions Author(s): Allen Loyd V Jr
Nov/Dec 2018 Pg. 497	Prednisone 5 mg/mL ir Oral Mix Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2018 Pg. 527	Errata Author(s): Allen Loyd V Jr
Sep/Oct 2018 Pg. 356	PreScription: Updating Formulations Author(s): Allen Loyd V Jr
Sep/Oct 2018 Pg. 408	Cysteamine 0.5% Ophthalmic Solution Author(s): Allen Loyd V Jr
Sep/Oct 2018 Pg. 409	Fluoxetine 50 mg/mL in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Sep/Oct 2018 Pg. 410	Pergolide Mesylate 0.2-mg/mL Oral Liquid, Veterinary Author(s): Allen Loyd V Jr
Sep/Oct 2018 Pg. 411	Torsemide 5 mg/mL in Ora-Plus:Ora-Sweet Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 268	PreScription: Factors Related to Drug Waste and Pharmacy Solutions Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 288-293	Quality Control: Water Activity Considerations for Beyond-use Dates Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 294-300	Basics of Compounding--Nonsterile: Compounding Self-emulsifying Drug Delivery Systems and Other Self-emulsifying Lipid Formulations, Part 2 Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 316	Anhydrous Medium-chain Triglycerides Gel Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 317	Budesonide 1-mg//10-mL Mucolox Oral Suspensions Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 318	Cinacalcet 5-mg/mL in Oral-Plus/Ora-Sweet Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 319	Ketoprofen 10% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 320	Metronidazole Benzoate 70 mg/mL in SyrSpend SF Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 321	Midazolam 1 mg/mL in SyrSpend SF or SyrSpend SF Cherry Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 322	Minoxidil 50 mg/mL in Espumil Foam Base Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 323	Oseltamivir Phosphate 15 mg/mL in SyrSpend SF Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 324	Pentoxifylline 5% in Dermabase Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 325	Propranolol Hydrochloride 1 mg/mL in SyrSpend SF Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2018 Pg. 180	PreScription: Influence and Sphere of Influence Author(s): Allen Loyd V Jr
May/Jun 2018 Pg. 206-217	Quality Control–Sterile Compounding: Analytical Methods. Density Determinations and Quality Control in Nonsterile and Sterile Compounding Author(s): Allen Loyd V Jr
May/Jun 2018 Pg. 220-228	Basics of Compounding–Nonsterile: Compounding Self-emulsifying Drug Delivery Systems and Other Self-emulsifying Lipid Formulations, Part 1 Author(s): Allen Loyd V Jr
May/Jun 2018 Pg. 232	Anhydrous Silicon Base Topical Gel Vehicle Author(s): Allen Loyd V Jr
May/Jun 2018 Pg. 233	Atenolol 1 mg/mL or 5 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
May/Jun 2018 Pg. 234	Dorzolamide 2% Ophthalmic Solution Author(s): Allen Loyd V Jr
May/Jun 2018 Pg. 235	Gabapentin 100 mg/mL in Oral Mix or Oral Mix SF Suspension Author(s): Allen Loyd V Jr
May/Jun 2018 Pg. 236	Pyrimethamine 2 mg/mL in Ora-Plus and Ora-Sweet Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2018 Pg. 237	Rolapitant Injectable Emulsion with Dexamethasone Sodium Phosphate Admixture Author(s): Allen Loyd V Jr
May/Jun 2018 Pg. 238	Simvastatin 1 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2018 Pg. 239	Trimethoprim 20 mg/mL and Sulfadiazine 100 mg/mL in Suspendit Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2018 Pg. 92	PreScription: Drug Quality and Security Act Implementation Subcommittee Hearing Author(s): Allen Loyd V Jr
Mar/Apr 2018 Pg. 95-107	Pharmacogenomics: Precision Pharmacy in 503A Compounding Author(s): Drummond Joseph, Bennet Daron, Allen Loyd V Jr
Mar/Apr 2018 Pg. 137-143	Basics of Compounding: Compounding Microemulsions Author(s): Allen Loyd V Jr
Mar/Apr 2018 Pg. 146	Clonidine Hydrochloride 10 mg/mL in Inorpha Solution Author(s): Allen Loyd V Jr
Mar/Apr 2018 Pg. 147	Dorzolamide 2% and Timolol 0.5% Ophthalmic Solution Author(s): Allen Loyd V Jr
Mar/Apr 2018 Pg. 148	Lamotrigine 1-mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2018 Pg. 149	Levodopa and Carbidopa Rectal Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2018 Pg. 150	Prochlorperazine Edisylate 0.5% Nasal Spray Author(s): Allen Loyd V Jr
Mar/Apr 2018 Pg. 151	Rolapitant Injectable Emulsion with Palonosetron Hydrochloride Admixture Author(s): Allen Loyd V Jr
Mar/Apr 2018 Pg. 152	Spironolactone 5-mg/mL in Suspendit Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2018 Pg. 153	Trilostane 5-mg/mL in Cod Liver Oil Suspension (Vet) Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 4	PreScription: 2017--Some Good Things Happened and Some Others Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 7-16	Certification, Accreditation, and Credentialing for 503A Compounding Pharmacies Author(s): Pritchett Jon, McCrory Gary, Kraemer Cheri, Jensen Brenda, Allen Loyd V Jr
Jan/Feb 2018 Pg. 50	Glutamate and Aspartate Cardioplegia Additive Solution Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 51	Mercaptopurine 50 mg/mL in Ora-Sweet and Ora-Plus Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 52	Metronidazole 50 mg/mL in Ora-Blend Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 53	Miconazole 10% in Recura Topical Cream Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 54	Naproxen 25 mg/mL in Oral Mix or Oral Mix SF Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 55	Penicillamine-D 50 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 56	Ranitidine 15 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 57	Sodium Citrate 9% Nasal Spray for Olfactory Disorders Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 58	Thalidomide 20 mg/mL in Ora-Plus and Ora-Sweet Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 59	Voriconazole 40-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2017 Pg. 444	PreScription: Issues with the NAMS 2017 Hormone Therapy Position Statement Author(s): Allen Loyd V Jr
Nov/Dec 2017 Pg. 481-486	Basics of Compounding: Compounding Irrigation Solutions for Sterile and Nonsterile Preparations Author(s): Allen Loyd V Jr
Nov/Dec 2017 Pg. 490	Amitriptyline 20 mg/mL in OraPlus:OraSweet Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2017 Pg. 491	Dapsone 2 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2017 Pg. 492	Fluconazole 10% in RECURA Cream Author(s): Allen Loyd V Jr
Nov/Dec 2017 Pg. 493	Haloperidol 5-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2017 Pg. 494	Hydroxychloroquine Sulfate 25 mg/mL in Oral Mix or Oral Mix SF Author(s): Allen Loyd V Jr
Nov/Dec 2017 Pg. 495	Promethazine Hydrochloride 12.5 mg/0.1 mL in PLO Gel Author(s): Allen Loyd V Jr
Nov/Dec 2017 Pg. 496	Spironolactone 5 mg/mL in SuspendIt Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2017 Pg. 497	Tolmetin 400-mg Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2017 Pg. 498	Trace Elements Injection 5 Author(s): Allen Loyd V Jr
Nov/Dec 2017 Pg. 499	Vancomycin 5-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 356	PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 364-370	Child-safety Containers/Devices and Compounding Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 388-392	Basics of Compounding: 3D Printing--Pharmacy Applications: Geometric Shape Effects on 3D Printing Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 408	Acetylcysteine Solutions for Inhalation Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 409	Carbamazepine 25-mg/mL in SyrSPend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 410	Etoposide 20-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 411	Fentanyl Citrate 50-mcg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 412	Fluoxymesterone 10-mg Capsules Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 413	Ioversol Injection Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 414	Levocarnitine 100-mg/mL Oral Solution Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 415	Peritoneal Dialysis Solution with 1.5%, 2.5%, or 4.25% Dextrose Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 416	Tacrolimus 0.3-mg/mL Ophthalmic Solution Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 417	Vancomycin 50 mg/mL in Oral Syrup Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 268	PreScription: Just Think About It! Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 293-298	Basics of Compounding: 3D Printing: Pharmacy Applications, Part 3: Compounding, Formulation Considerations, and the Future Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 312	Betamethasone 0.1% and Neomycin 0.6% Gel-Cream Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 313	Castor Oil 50% in Modified Pluronic Lecithin Organogel Gel Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 314	Copper Sulfate, Magnesium Sulfate, Phenylephrine, and Guaifenesin Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 315	Disopyramide 100-mg Capsules Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 316	Ferrous Sulfate 30-mg Fe/mL Oral Drops Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 317	Reteplase Injection Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 318	Sertraline Hydrochloride 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 319	Tacrolimus 0.06% Ophthalmic Drops Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 320	Torsemide 10-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 321	Tranilast 8% Pluronic Lecithin Organogel Gel Author(s): Allen Loyd V Jr
May/Jun 2017 Pg. 180	PreScription: United States Pharmacopeia Chapter <800> Comments and Alternatives Author(s): Allen Loyd V Jr
May/Jun 2017 Pg. 215-220	Basics of Compounding: 3D Printing--Pharmacy Applications, Part 2 Author(s): Allen Loyd V Jr
May/Jun 2017 Pg. 232	Candesartan Cilexetil 0.1-mg/mL to 2.0-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2017 Pg. 233	Ketoconazole 20-mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2017 Pg. 234	Ketoprofen 10%, Baclofen 2%, Cyclobenzaprine Hydrochloride 2%, Lidocaine 2% in Lipopen Ultra Cream Base Author(s): Allen Loyd V Jr
May/Jun 2017 Pg. 235	Meloxicam 1% Topical Gel Author(s): Allen Loyd V Jr
May/Jun 2017 Pg. 236	Ofloxacin 0.3% Ophthalmic Solution Author(s): Allen Loyd V Jr
May/Jun 2017 Pg. 237	PVP Iodine 10% Antiseptic Cream Author(s): Allen Loyd V Jr
May/Jun 2017 Pg. 238	Tri-Est, Progesterone, and Testosterone in Versatile, Phytobase, Fitaline, and HRT Supreme Cream Bases Author(s): Allen Loyd V Jr
May/Jun 2017 Pg. 239	Trimethoprim 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2017 Pg. 92	PreScription: Whatever Happened to Common Sense? Author(s): Allen Loyd V Jr
Mar/Apr 2017 Pg. 118-124	Quality Control: (Material) Safety Data Sheets Author(s): Allen Loyd V Jr
Mar/Apr 2017 Pg. 127-130	Basics of Compounding: 3D Printing--Pharmacy Applications, Part 1 Author(s): Allen Loyd V Jr
Mar/Apr 2017 Pg. 146	Azathioprine 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2017 Pg. 147	Candesartan Cilexetil 8 mg Liquid-Filled Capsules Author(s): Allen Loyd V Jr
Mar/Apr 2017 Pg. 148	Furosemide 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2017 Pg. 149	Ketoconazole 20-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2017 Pg. 4	PreScription: Compounding Pharmacy Issues for 2017 Author(s): Allen Loyd V Jr
Jan/Feb 2017 Pg. 31-37	Analytic Methods Used in Quality Control in a Compounding Pharmacy Author(s): Allen Loyd V Jr
Jan/Feb 2017 Pg. 39-45	Basics of Compounding with Dilutions and Concentrates Author(s): Allen Loyd V Jr
Jan/Feb 2017 Pg. 60	Clindamycin 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2017 Pg. 61	Diazoxide 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2017 Pg. 62	Infliximab 1% Ophthalmic Solution Author(s): Allen Loyd V Jr
Jan/Feb 2017 Pg. 63	Nifedipine 0.5% Rectal Ointment Author(s): Allen Loyd V Jr
Jan/Feb 2017 Pg. 64	Tetracaine Hydrochloride 0.5% Ophthalmic Solution Author(s): Allen Loyd V Jr
Jan/Feb 2017 Pg. 65	Zonisamide 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 444	PreScription: Two Decades of IJPC Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 481-484	Introduction to Quality Control in a Compounding Pharmacy Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 485-493	Basics of Compounding: Clinical Pharmaceutics, Part 2 Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 495-500	Basics of Sterile Compounding: Ophthalmic Preparations, Part 2: Suspensions and Ointments Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 504	Alendronate 70-mg/75-mL Drinkable Formulation Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 505	Bosentan 6.25-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 506	Capsaicin 0.025% and Doxepin 3.3% Cream Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 507	Enrofloxacin 0.5%, Ketoconazole 0.1%, and Triamcinolone Acetonide 0.1% Otic Gel Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 508	Erlotinib 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 509	Flumazenil 0.1-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 510	Imatinib 40-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 511	Lapatinib Ditosylate 50-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 512	Melatonin 2-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 513	Menthol, Chloral Hydrate, and Camphor Analgesic Ointment Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 356	PreScription: Stability Studies and United States Pharmacopeia-National Formulary-Grade Chemicals Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 389-396	Basics of Compounding: Clinical Pharmaceutics, Part 1 Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 399-404	Basics of Sterile Compounding: Ophthalmic Preparations, Part 1: Ophthalmic Solutions Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 406	Clobazam 1-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 407	Estradiol 0.25 mg/g, Estrone 0.25 mg/g, and Estriol 2 mg/g in HRT Cream Base Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 408	Inamrinone 5-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 409	Levetiracetam 50-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 410	Naproxen 5% Cream Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 411	Permethrin 1% Lotion Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 412	Progesterone 10% Cream Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 413	Sodium Phosphate Oral Solution Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 414	Tetracaine Hydrochloride 2% Topical Solution Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 415	Tromethamine Injection Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 268 View Sample	PreScription: Is the United States Pharmacopeial Convention, Inc., Authorized to Establish "Official" Practice Standards for Pharmacy, Medicine, and Nursing? Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 298-305	Basics of Compounding: Compounding Films Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 318	Dolasetron Mesylate 20-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 319	Gatifloxacin 0.5% Ophthalmic Solution Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 320	Mebendazole 100-mg Capsules Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 321	Neomycin Sulfate 25-mg/mL Oral Solution Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 322	Nystatin 100,000-units Vaginal Inserts Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 323	1,2-Octanediol 5% Topical Liquid Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 324	Phytonadione 1-mg/mL Oral Solution Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 325	Plasmingen and Hyaluronate Sodium Ophthalmic Solution Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 326	Scopolamine Hydrobromide 0.25% Ophthalmic Solution Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 327	Tretinoin 10-mg Oral Capsules Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 351 View Sample	Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 180	PreScription: Patient Access to Pharmaceuticals Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 209-214	Basics of Compounding: Special Capsules Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 226	Carboplatin 50-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 227	Cefotetan Disodium Injection Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 228	Dexamethasone 0.1%, Neomycin 0.35%, and Polymixin 10,000 Units/g Ophthalmic Ointment Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 229	Dexpanthenol 5% Nasal Spray Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 230	Indomethacin Gel Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 231	Ketamine Hydrochloride 5%, Gabapentin 10%, Clonidine Hydrochloride 0.2%, and Baclofen 2% in Lipoderm Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 232	Montelukast Sodium 5-mg Fast-Dissolving Film Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 233	Pain-Away II Headache Capsules Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 234	Sodium Nitroprusside 25-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 235	Zolpidem Tartrate 5-mg and 10-mg Capsules Author(s): Allen Loyd V Jr
Mar/Apr 2016 Pg. 92	PreScription: Compounding: A Changing Paradigm Author(s): Allen Loyd V Jr
Mar/Apr 2016 Pg. 125-134	Basics of Compounding: Capsules Author(s): Allen Loyd V Jr
Mar/Apr 2016 Pg. 144	Blue Goo Anti-Itch Gel Author(s): Allen Loyd V Jr
Mar/Apr 2016 Pg. 145	Carvedilol 3.125-mg, 6.25-mg, 12.5 mg, or 25-mg capsules Author(s): Allen Loyd V Jr
Mar/Apr 2016 Pg. 146	Medicated Polyox Bandage for Skin Ulcers Author(s): Allen Loyd V Jr
Mar/Apr 2016 Pg. 147	Sumatriptan 5-mg or 20-mg per 100-μL Nasal Spray Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 4	PreScription: Starting Year 20! Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 48	Aprepitant 80-mg Capsules Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 49	Aripiprazole 10-mg Oral Dissolving Tablets Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 50	Benzocaine 20%, Lidocaine 6%, and Tetracaine 4% in Lipoderm Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 51	Dexamethasone, Neomycin, and Polymyxin Ophthalmic Ointment Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 52	Mupirocin Calcium 2% Cream Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 53	Resveratrol, Tocopherol Acetate, and Niacinamide Topical Gel-Cream Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 54	Thrombin 1,000 Units/mL Topical Solution, Sterile Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 55	Tropicamide 1% Ophthalmic Solution Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 56	Vancomycin 5% and Amikacin 2% Ophthalmic Solution Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 57	Voriconazole 10-mg/mL Ophthalmic Solution Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 442	PreScription: The Documented Past and the Exciting Future Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 487-488	U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 504	Acetominophen and Codeine Phosphate (300-mg/30-mg) Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 505	Cefepime Hydrochloride 100-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 506	Cefotaxime 100-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 507	Chlorpromazine Hydrochloride 25-mg/mL Injection, Preserved Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 508	Dexamethasone Sodium Phosphate Ophthalmic Solution: Equivalent to 0.1% Dexamethasone Phosphate Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 509	Estradiol Valerate 40-mg/mL in Oil Injection Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 510	Levetiracetam 100-mg/mL Injection (Concentrate) Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 511	Memantine Hydrochloride Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 512	Mupirocin 2% Nasal Ointment Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 513	Propranolol Hydrochloride Capsules Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 354	PreScription: Failure or Success? Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 389-390	Nominations of Difficult to Compound Drugs to the U.S. Food and Drug Administration--Pharmacy Compounding Advisory Committee: Part 1 Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 404	Aminocaproic Acid 250-mg/mL Oral Solution Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 405	Betamethasone Valerate 0.12%, Tranilast 1% Topical Gel Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 406	Lidocaine 2%, Metronidazole 2%, Misoprostol 0.0024% Topical Ointment Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 407	Nimodipine 3-mg/mL Oral Solution Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 408	Ofloxacin 0.3% Otic Solution Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 409	Povidone Iodine 10% Cold Sore Paint Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 410	Trichloroacetic Acid 20%, Salicylic Acid 20%, Lactic Acid 10% in Flexible Collodion Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 411	Vehicle for Oral Solution (National Formulary 26) Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 412	Vehicle for Oral Solution, Sugar Free (National Formulary 26) Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 413	Vehicle for Oral Suspension (National Formulary 26) Author(s): Allen Loyd V Jr
May/Jun 2015 Pg. 180	PreScription: 2015 Student Pharmacist Compounding Competition Author(s): Allen Loyd V Jr
May/Jun 2015 Pg. 223-230	Basics of Compounding: Compounding with Silicones Author(s): Allen Loyd V Jr
May/Jun 2015 Pg. 242	Atropine Sulfate 1% Ophthalmic Solution Author(s): Allen Loyd V Jr
May/Jun 2015 Pg. 243	Lidocaine Hydrochloride 2% Viscous Oral Topical Solution Author(s): Allen Loyd V Jr
May/Jun 2015 Pg. 244	Methylphenidate Hydrochloride 2.5-mg, 5-mg, or 10-mg Chewable Troches Author(s): Allen Loyd V Jr
May/Jun 2015 Pg. 245	Phenazopyridine Hydrochloride 200-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2015 Pg. 246	Physostigmine Salicylate 1-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2015 Pg. 247	Scopolamine Hydrobromide -.4-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2015 Pg. 92	PreScription: Some of the Best Sermons are Lived, not Preached! Author(s): Allen Loyd V Jr
Mar/Apr 2015 Pg. 142	Acne Scrub Author(s): Allen Loyd V Jr
Mar/Apr 2015 Pg. 143	Aminohippurate Sodium 200-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2015 Pg. 144	Deferoxamine Mesylate 213/mg/mL or 95-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2015 Pg. 145	Heparin 335-United/Gram Gel-Cream Author(s): Allen Loyd V Jr
Mar/Apr 2015 Pg. 146	L-Cysteine Hydrochloride 50-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2015 Pg. 147	Morrhuate Sodium 5% Injection Author(s): Allen Loyd V Jr
Mar/Apr 2015 Pg. 148	Oxycodone Hydrochloride 5-mg and Acetaminophen 325-mg per 5-mL Oral Solution Author(s): Allen Loyd V Jr
Mar/Apr 2015 Pg. 149	Pancuronium Bromide 1-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2015 Pg. 150	Physostigmine Salicylate 1-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2015 Pg. 151	Trypan Blue 0.06% Ophthalmic Solution Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 4	PreScription: 2014 in Review Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 38-40	Biotechnology, Nanotechnology, and Pharmacogenomics and Pharmaceutical Compounding, Part 1 Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 43-47	Quality Control Analytical Methods: Refractive Index Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 57-58	Basics of Compounding: The Revised "Not to Compound List" Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 60	Atenolol 25-, 50-, or 100-mg Capsules Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 61	Azathioprine 50-mg Capsules Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 62	Cisplatin 1-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 63	Daunorubicin 5-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 64	Erythromycin 50-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 65	Hydralazine Hydrochloride 20-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 66	Hydroxychloroquine Sulfate 200-mg Capsules Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 67	Lidocaine Hydrochloride 4% Topical Solution Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 68	Mupirocin 2% Ointment Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 69	Phentolamine Mesylate 5-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 444	PreScription: "Named Formulas" Database Available Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 486-488	Basics of Compounding: Tips and Hints, Part 6: Prescription Evaluation, Calculations, Ingredients, Quality-Assurance Practices, Patient Counseling, Shipping and Distribution, Miscellaneous Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 494	Clarithromycin 250-mg or 500-mg Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 495	Dexmedetomidine 100 mcg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 496	Dexmethylphenidate Hydrochloride 2.5-mg, 5-mg, or 10-mg Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 497	Leucovorin 10-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 498	Levocarnitine 200-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 499	Methazolamide 25-mg or 50-mg Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 500	Methylene Blue 10-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 501	Methylphenidate Hydrochloride 10-mg Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 502	Oxacillin Sodium 167-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 503	Tamsulosin Hydrochloride 0.2-mg Capsules Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 356	PreScription: What is a Compounding Pharmacist? Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 401-404	Basics of Compounding: Tips and Hints, Part 5: Facilities and Equipment Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 408	Azithromycin 100-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 409	Bacitracin Topical Ointment Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 410	Dexpanthenol 250-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 411	Ephedrine Sulfate 50-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 412	Fluorescein 100-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 413	Indocyanine green 2.5-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 414	Phenylephrine Hydrochloride 2.5%-Ophthalmic Solution Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 415	Sulfamethoxazole and Trimethoprim Oral Solution Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 416	Sumatriptan Succinate 12-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 417	Tranexamic Acid 100-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 268	PreScription: Challenging Times Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 313-317	Basics of Compounding Sterile Preparations: Nomenclature and Considerations Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 318-319	Basics of Compounding: Tips and Hints, Part 4: Lollipops/Lozenges, Gummy Bears, Patches, Flavoring/Coloring, Sweeteners, and Packaging Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 322	Atracurium Besylate 10-mg/mL Injection, Preserved Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 323	Barium Sulfate Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 324	Calcitriol 1-mcg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 325	Chloramphenicol 100-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 326	Chlorothiazide 50-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 327	Choline Magnesium Trisalicylate Liquid Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 328	Denileukin Diftitox 150-mcg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 329	Indigo Carmine Injection Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 330	Propranolol Hydrochloride 1-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 331	Zinc 1-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 351	PostScription: Responsibilities of a Compounding Pharmacist Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 180	PreScription: Déjà Vu All Over Again Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 228-230	Basics of Compounding: Tips and Hints, Part 3: Compounding with Ointments, Creams, Pastes, Gels, and Gel-creams Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 232	Atorvastatin 10-mg or 20-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 233	Bumetanide 0.5-mg, 1-mg, or 2-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 234	Bupivacaine Hydrochloride 0.5% Injection Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 235	Butorphanol Tartrate 10-mg/mL Nasal Spray Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 236	Dibucaine 1% Ointment Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 237	Lidocaine Hydrochloride 1% Injection Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 238	Methotrexate 2.5-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 239	Naproxen 25-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 240	Tamoxifen 10-mg or 20-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 241	Thiothixene 1-mg, 2-mg, 5-mg, or 10-mg Capsules Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 92	PreScription: Standards vs Opinions Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 131-134	Basics of Sterile Compounding: Compounding by Weight Versus Compounding by Volume Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 137-138	Basics of Compounding: Tips and Hints, Part 2: Compounding with Solutions, Suspensions, Emulsions, and Lotions Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 142	Doxazosin 1-mg, 2-mg, 4-mg, or 8-mg Capsules Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 143	Fludarabine Phosphate 25-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 144	Mecasermin 10-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 145	Methylprednisolone 40-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 146	Polymixin B Injection Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 147	Rocuronium Bromide 10-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 148	Secretin 4 mcg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 149	Selenium 40-mcg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 150	Sincalide 1-mcg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 151	Testosterone Enanthate 200-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 4	PreScription: The International Journal of Pharmaceutical Compounding Begins Its 18th Year Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 42-45	Tips and Hints: Powders, Capsules, Tablets, Suppositories, and Sticks Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 60	Aztreonam Injection Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 61	Bumetanide 0.25-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 62	Droperidol 2.5-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 63	Lomustine 100-mg Capsules Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 64	Neostigmine Bromide 15-mg Capsules Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 65	Nimodipine 30-mg Capsules Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 66	Phenobarbital 60-mg Capsules Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 67	Potassium Chloride 2-mEq/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 68	Procainamide Hydrochloride 100-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 69	Vasopressin 20-units/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2013 Pg. 444	PreScription: Two Milestones for the International Journal of Pharmaceutical Compounding Author(s): Allen Loyd V Jr
Nov/Dec 2013 Pg. 477-479	Physicians, Pharmacists, and the Importance of Quality Pharmacy Compounding Author(s): Allen Loyd V Jr
Nov/Dec 2013 Pg. 490-495	Basics of Compounding: Basics of Compounding with Balsams Author(s): Allen Loyd V Jr
Nov/Dec 2013 Pg. 498	Benztropine Mesylate 1-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2013 Pg. 499	Cefazolin 250-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2013 Pg. 500	Ciprofloxacin 250-mg Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2013 Pg. 501	Cortisone Acetate 25-mg Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2013 Pg. 502	Cyclopentolate Hydrochloride 0.2% and Phenylephrine Hydrochloride 1% Ophthalmic Solution Author(s): Allen Loyd V Jr
Nov/Dec 2013 Pg. 503	Dihydroergotamine Mesylate 1-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2013 Pg. 504	Hydrocortisone 50-mg/mL Injection (as the Sodium Succinate) Author(s): Allen Loyd V Jr
Nov/Dec 2013 Pg. 505	Levothyroxine Sodium 100-mcg Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2013 Pg. 506	Metyrosine 250-mg Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2013 Pg. 507	Phenytoin Sodium 50-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2013 Pg. 526-527	PostScription: Augmented Reality for Readers and Authors Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 356	PreScription: GMPs vs. GCPs: Manufacturing and Compounding Definitions Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 400-410	Basics of Compounding: Basics of Compounding with Tars Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 414	Acyclovir 50-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 415	Aminocaproic Acid 250-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 416	Clindamycin 150-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 417	Fluorouracil 50-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 418	Hydroxyzine Hydrochloride 25-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 419	Indomethacin 1-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 420	Mesna 100-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 421	Methotrexate 25-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 422	Phenylephrine Hydrochloride 10-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 423	Terbutaline Sulfate 1-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 439	PostScription: GMPs vs. GCPs: United States Pharmacopeia General Chapters Author(s): Allen Loyd V Jr
Jul/Aug 2013 Pg. 268	Prescription: International Journal of Pharmaceutical Compounding and MEDLINE Update Author(s): Allen Loyd V Jr
Jul/Aug 2013 Pg. 312-322	Basics of Compounding: Foam Dosage Forms Author(s): Allen Loyd V Jr
Jul/Aug 2013 Pg. 326	Acyclovir 20-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2013 Pg. 327	Acyclovir 200-mg Capsules Author(s): Allen Loyd V Jr
Jul/Aug 2013 Pg. 328	Allopurinol Sodium 4-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2013 Pg. 329	Amikacin Sulfate 250-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2013 Pg. 330	Dacarbazine 200-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2013 Pg. 331	Ketamine 50-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2013 Pg. 332	Methohexital Sodium 500-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2013 Pg. 333	Metoprolol Tartrate 1-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2013 Pg. 334	Rifampin 300-mg and Isoniazid 150-mg Capsules Author(s): Allen Loyd V Jr
Jul/Aug 2013 Pg. 335	Succinylcholine Chloride 50-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2013 Pg. 351	PostScription: Traditional vs Nontraditional Pharmacy Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 180	PreScription: Compounding for Drug Shortages Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 210-219	Quality Control Analytical Methods: A Summarized Discussion of Current Good Manufacturing Practice Regulations Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 220-224	Basics of Compounding: Potency and Stability Testing Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 228	Buffered Aspirin Capsules Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 229	Calcium Acetate 667-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 230	Estradiol 0.5-mg, 1-mg, or 2-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 231	Ethambutol 400-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 232	Isoniazid 300-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 233	Labetalol 50-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 234	Mercaptopurine 75-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 235	Naltrexone Hydrochloride 50-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 236	Prednisone 10-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 237	Reserpine 0.5-mg Capsules Author(s): Allen Loyd V Jr
Mar/Apr 2013 Pg. 92	PreScription: Pharmacy Committees Author(s): Allen Loyd V Jr
Mar/Apr 2013 Pg. 136-140	Basics of Compounding: Repackaging, Part 2 Author(s): Allen Loyd V Jr
Mar/Apr 2013 Pg. 144	Adenosine 3-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2013 Pg. 145	Alcohol Dehydrated Injection Author(s): Allen Loyd V Jr
Mar/Apr 2013 Pg. 146	Betahistine 16-mg Capsules Author(s): Allen Loyd V Jr
Mar/Apr 2013 Pg. 147	Ciprofloxacin 10-mg/mL Intravenous Injection Concentrate Author(s): Allen Loyd V Jr
Mar/Apr 2013 Pg. 148	Cyanocobalamin 1000-mcg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2013 Pg. 149	Dexrazoxane 1-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2013 Pg. 150	Meropenem 50-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2013 Pg. 151	Paclitaxel 6-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2013 Pg. 152	Thiotepa 15-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2013 Pg. 153	Verapamil Hydrochloride 2.5-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 4	PreScription: How Many Pharmacies Compound and What Do They Compound? Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 39-44	Adrenal Fatigue Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 50-53	Quality Control: Analytical Methods: Calibration of Equipment and Calibration Curves Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 54-60	Basics of Compounding: Repackaging, Part 1 Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 64	Desmopressin 4-mcg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 65	Dobutamine 10-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 66	Granisetron 1-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 67	Ibuprofen 10-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 68	Mepivacaine Hydrochloride 1% Injection Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 69	Milrinone 0.2-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 70	Neostigmine Methylsulfate 0.5-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 71	Nicardipine Hydrochloride Injection Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 72	Octreotide 50-mcg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 73	Testosterone Cypionate 100-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 86	Errata Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 87	PostScription: GMPs and GCPs: A Topical Comparison Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 444	PreScription: A Degree in Pharmacy: How Valuable! Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 480-483	Colds and Cough Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 486-488	Quality Control: Analytical Methods. Certificates of Analysis, Part 1 Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 490-496	Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 5: Outsourcing and Responsible Personnel Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 500	Aminophylline 25-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 501	Ammonium Chloride 5-mEq/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 502	Azathioprine 10-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 503	Copper 0.4-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 504	Dipyridamole 5-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 505	Dopamine Hydrochloride 80-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 506	Ergotamine Tartrate 1-mg and Caffeine 100-mg Capsules Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 507	Papaverine Hydrochloride 30-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 508	Valproate Sodium 100-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 509	Vercuronium Bromide 1-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2012 Pg. 356	PreScription: What Is Involved in the Making of Remington's? Author(s): Allen Loyd V Jr
Sep/Oct 2012 Pg. 358-362	Remington: The Science and Practice of Pharmacy: From the Past into the Future Author(s): Allen Loyd V Jr
Sep/Oct 2012 Pg. 425	Metronidazole 5-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2012 Pg. 405-414	Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 4: Cleaning and Packaging Author(s): Allen Loyd V Jr
Sep/Oct 2012 Pg. 418	Doxapram Hydrochloride 20-mg/mL injection Author(s): Allen Loyd V Jr
Sep/Oct 2012 Pg. 419	Enalaprilat 1.25-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2012 Pg. 420	Esmolol Hydrochloride 10-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2012 Pg. 421	Fluconazole 2-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2012 Pg. 422	Haloperidol 50-mg/mL in Oil Injection Author(s): Allen Loyd V Jr
Sep/Oct 2012 Pg. 423	Meperidine Hydrochloride 50-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2012 Pg. 424	Methocarbamol 100-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2012 Pg. 426	Nalbuphine Hydrochloride 10-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2012 Pg. 427	Oxymorphone Hydrochloride 1-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2012 Pg. 438	PostScription: Remington Twenty-Second Edition Author(s): Allen Loyd V Jr
Jul/Aug 2012 Pg. 268	PreScription: Lifelong Learning Author(s): Allen Loyd V Jr
Jul/Aug 2012 Pg. 268	PreScription: Drug Shortages and Discontinued Drugs Author(s): Allen Loyd V Jr
Jul/Aug 2012 Pg. 270-274	A Concise Discussion of Headache Types, Part 3: Migraine Author(s): Williams LaVonn A, Allen Loyd V Jr
Jul/Aug 2012 Pg. 294-298	Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers Author(s): Allen Loyd V Jr, Williams LaVonn A
Jul/Aug 2012 Pg. 322-328	Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 3: Testing Author(s): Allen Loyd V Jr
Jul/Aug 2012 Pg. 332	Betamethasone 0.6-mg/5-mL Syrup Author(s): Allen Loyd V Jr
Jul/Aug 2012 Pg. 333	Butorphanol Tartrate 2-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2012 Pg. 334	Diphenhydramine Hydrochloride 50-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2012 Pg. 335	Etomidate 2-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2012 Pg. 336	Foscarnet Sodium 24-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2012 Pg. 337	Ketorolac Tromethamine 15-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2012 Pg. 338	Methyldopate Hydrochloride 50-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2012 Pg. 339	Ondansetron Hydrochloride 2-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2012 Pg. 340	Sufentanil Citrate 50-mcg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2012 Pg. 341	Tobramycin 40-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2012 Pg. 350-351	PostScription: Drug Shortages and Discontinued Drugs: Their Effects on Healthcare Author(s): Allen Loyd V Jr, Williams LaVonn A
May/Jun 2012 Pg. 180	PreScription: You're On Your Own Author(s): Allen Loyd V Jr
May/Jun 2012 Pg. 210-218	Treatment and Prevention of Insect Bites: Mosquitoes Author(s): Williams LaVonn A, Allen Loyd V Jr
May/Jun 2012 Pg. 230-234	Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 2: Documentation and Verification Author(s): Allen Loyd V Jr
May/Jun 2012 Pg. 238	Acetazolamide 100-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2012 Pg. 239	Alfentanil 500-mcg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2012 Pg. 240	Ascorbic Acid 250-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2012 Pg. 241	Diltiazem Hydrochloride 5-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2012 Pg. 242	Famotidine 10-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2012 Pg. 243	Metoclopramide 5-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2012 Pg. 244	Naloxone Hydrochloride 1-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2012 Pg. 245	Orphenadrine Citrate 30-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2012 Pg. 246	Prochlorperazine 5-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2012 Pg. 247	Ranitidine 25-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2012 Pg. 92	PreScription: Support the Organizations that Support You and Your Practice Author(s): Allen Loyd V Jr
Mar/Apr 2012 Pg. 162	Midazolam 5-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2012 Pg. 163	Promethazine Hydrochloride 50-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2012 Pg. 146-150	Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 1 Author(s): Allen Loyd V Jr
Mar/Apr 2012 Pg. 154	Amiodarone Hydrochloride 50-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2012 Pg. 155	Bupivacaine Hydrochloride 0.5% with Epinephrine 1:200,000 Injection Author(s): Allen Loyd V Jr
Mar/Apr 2012 Pg. 156	Caffeine Citrate 20-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2012 Pg. 157	Chromium 4-mcg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2012 Pg. 158	Furosemide 10-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2012 Pg. 159	Glycopyrrolate 0.2-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2012 Pg. 160	Labetalol Hydrochloride 5-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2012 Pg. 161	Lorazepam 4-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2012 Pg. 77	Sodium Chloride 14.6% and 23.4% Injections Author(s): Allen Loyd V Jr
Jan/Feb 2012 Pg. 78	Sodium Phosphates Injection Author(s): Allen Loyd V Jr
Jan/Feb 2012 Pg. 79	Zinc 1-mg/mL and 5-mg/mL Injections Author(s): Allen Loyd V Jr
Jan/Feb 2012 Pg. 4	PreScription: Fifteen Years and Counting Author(s): Allen Loyd V Jr
Jan/Feb 2012 Pg. 75	Sodium Acetate 2-mEq/mL and 4-mEq/mL Injections Author(s): Allen Loyd V Jr
Jan/Feb 2012 Pg. 76	Sodium Bicarbonate 4.2%, 5.0%, 7.5%, and 8.4% Injections Author(s): Allen Loyd V Jr
Jan/Feb 2012 Pg. 64-68	Basics of Compounding: Implementing United States Pharmacopeia Chapter <795> Pharmaceutical Compounding–Nonsterile Preparations, Part 4 Author(s): Allen Loyd V Jr
Jan/Feb 2012 Pg. 70	Calcium Chloride 10% Injection Author(s): Allen Loyd V Jr
Jan/Feb 2012 Pg. 71	Calcium Gluconate 10% Injection Author(s): Allen Loyd V Jr
Jan/Feb 2012 Pg. 72	Magnesium Sulfate 10% Injection (0.8 mEq/mL) Author(s): Allen Loyd V Jr
Jan/Feb 2012 Pg. 73	Potassium Acetate 2-mEq/mL and 4-mEq/mL Injections Author(s): Allen Loyd V Jr
Jan/Feb 2012 Pg. 74	Potassium Phosphates Injection Author(s): Allen Loyd V Jr
Nov/Dec 2011 Pg. 444	PreScription: Not All Pharmacists Should Compound! Author(s): Allen Loyd V Jr
Nov/Dec 2011 Pg. 488-496	Basics of Compounding: Implementing United States Pharmacopeia Chapter <795> Pharmaceutical Compounding--Nonsterile Preparations, Part 3 Author(s): Allen Loyd V Jr
Nov/Dec 2011 Pg. 500	Cefepime 1% Ophthalmic Solution Author(s): Allen Loyd V Jr
Nov/Dec 2011 Pg. 501	Citric Acid 3% Mouthrinse Solution Author(s): Allen Loyd V Jr
Nov/Dec 2011 Pg. 502	Dapsone 5% Topical Gel Author(s): Allen Loyd V Jr
Nov/Dec 2011 Pg. 503	Lavender Oil 4% in Polyethylene Glycol Ointment Author(s): Allen Loyd V Jr
Nov/Dec 2011 Pg. 505	Oxandrolone 2-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2011 Pg. 506	Thioguanine 20-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2011 Pg. 507	Tobramycin Fortified 13.5-mg/mL Ophthalmic Solution Author(s): Allen Loyd V Jr
Nov/Dec 2011 Pg. 508	Vancomycin 31-mg/mL Ophthalmic Solution Author(s): Allen Loyd V Jr
Nov/Dec 2011 Pg. 504	Morphine 6-mg/mL, Haloperidol 0.5-mg/mL, and Hyoscine 6-mg/mL Infusion Author(s): Allen Loyd V Jr
Nov/Dec 2011 Pg. 509	Vancomycin 2% in Silver Sulfadiazine Cream Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 356	PreScription: Third-party Inequities and Discrimination Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 408-414	Basics of Compounding: Implementing United States Pharmacopeia Chapter <795> Pharmaceutical Compounding--Nonsterile Preparations, Part 2 Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 418	Carvedilol 0.625-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 419	Granisetron Hydrochloride 0.2-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 420	Lorazepam 1-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 421	Metoprolol Tartrate 1.25-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 422	Nifedipine 1-mg/500-mg Oral Powder Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 423	Nifedipine 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 424	Rebamipide Rectal Enema Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 425	Sotalol 5-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 426	Sulfadiazine 100-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 427	Ursodiol 50-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2011 Pg. 308-315	Transdermals: The Skin as Part of a Drug Delivery System Author(s): Allen Loyd V Jr
Jul/Aug 2011 Pg. 328-331	Basics of Compounding: Implementing United States Pharmacopeia Chapter <795> Pharmaceutical Compounding--Nonsterile Preparations, Part 1 Author(s): Allen Loyd V Jr
Jul/Aug 2011 Pg. 334	Anesthetic Nasal Ointment Author(s): Allen Loyd V Jr
Jul/Aug 2011 Pg. 335	Citric Acid, Potassium Citrate, and Sodium Citrate Solution Author(s): Allen Loyd V Jr
Jul/Aug 2011 Pg. 336	Cromolyn Sodium 50-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2011 Pg. 337	Glycopyrrolate 0.5-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2011 Pg. 338	Hydrocortisone 100-mg/60-mL Retention Enema Author(s): Allen Loyd V Jr
Jul/Aug 2011 Pg. 339	Magnesium Sulfate Paste Author(s): Allen Loyd V Jr
Jul/Aug 2011 Pg. 342	Quetiapine Fumarate 40-mg/mL Nonaqueous Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2011 Pg. 343	Riboflavin 5-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2011 Pg. 268	PreScription: The Science and Technology of Hospital Pharmacy Newsletter Author(s): Allen Loyd V Jr
Jul/Aug 2011 Pg. 340	Methylprednisolone 4-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2011 Pg. 341	Oxandrolone 1-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2011 Pg. 262	PostScription: Announcement Author(s): Allen Loyd V Jr
May/Jun 2011 Pg. 180	PreScription: Greed Does Not Pay! Makena, Lucentis, and Others Author(s): Allen Loyd V Jr
May/Jun 2011 Pg. 234-238	Basics of Compounding: Basics of Compounding with Complex Organic Molecules Author(s): Allen Loyd V Jr
May/Jun 2011 Pg. 242	Amitriptyline 4%, Dextromethorphan Hydrobromide 20%, and Tramadol Hydrochloride 5% in Pluronic Lecithin Organogel Gel Author(s): Allen Loyd V Jr
May/Jun 2011 Pg. 243	Diclofenac Sodium 1% Topical Gel Author(s): Allen Loyd V Jr
May/Jun 2011 Pg. 244	Ibuprofen 5% Topical Cream Author(s): Allen Loyd V Jr
May/Jun 2011 Pg. 246	Melatonin 1-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2011 Pg. 247	Sport Body Cooler Author(s): Allen Loyd V Jr
May/Jun 2011 Pg. 248	Tannic Acid 5% Alcohol Gel Author(s): Allen Loyd V Jr
May/Jun 2011 Pg. 249	Triamcinolone 0.1% Lotion Author(s): Allen Loyd V Jr
May/Jun 2011 Pg. 245	Ketoprofen 10%, Ibuprofen 10%, Cyclobenzaprine Hydrochloride 2%, and Piroxicam 2% in Pluronic Lecithin Organogel Gel Author(s): Allen Loyd V Jr
May/Jun 2011 Pg. 250	Triclosan 2% Topical Cream Author(s): Allen Loyd V Jr
May/Jun 2011 Pg. 251	Wound Cleaner Solution Author(s): Allen Loyd V Jr
Mar/Apr 2011 Pg. 92	PreScription: Discontinued Drugs and Drug Shortages Author(s): Allen Loyd V Jr
Mar/Apr 2011 Pg. 146-153	Basics of Compounding: Basics of Compounding with Inorganic Salts Author(s): Allen Loyd V Jr
Mar/Apr 2011 Pg. 156	Acetylcysteine 1% or 10% Oral Solution Author(s): Allen Loyd V Jr
Mar/Apr 2011 Pg. 157	Amitriptyline Hydrochloride 2%, Carbamazepine 2%, Gabapentin 10%, and Ketoprofen 2% Transdermal Gel Author(s): Allen Loyd V Jr
Mar/Apr 2011 Pg. 158	Clopidogrel 5-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2011 Pg. 159	Dextromethorphan Hydrobromide 15-mg Oral Film Strip Author(s): Allen Loyd V Jr
Mar/Apr 2011 Pg. 160	Hank's Balanced Salt Solution (Stock Solution) Author(s): Allen Loyd V Jr
Mar/Apr 2011 Pg. 161	Levamisole 25-mg/mL Oral Solution Author(s): Allen Loyd V Jr
Mar/Apr 2011 Pg. 162	Mandl's Paint Author(s): Allen Loyd V Jr
Mar/Apr 2011 Pg. 163	Massage Rub, Oil Free Author(s): Allen Loyd V Jr
Mar/Apr 2011 Pg. 164	Oral Film Strip Vehicle Author(s): Allen Loyd V Jr
Mar/Apr 2011 Pg. 165	Tea Tree Oil Acne Gel Author(s): Allen Loyd V Jr
Mar/Apr 2011 Pg. 175	Erratum: Stability of Venlafaxine Immediate-Release Suspensions Author(s): Allen Loyd V Jr
Jan/Feb 2011 Pg. 4	PreScription: The Resources of the International Journal of Pharmaceutical Compounding, Inc.; Sterile Compounding Meets Needs for Patients, Professionals Author(s): Allen Loyd V Jr, Menighan Thomas E
Jan/Feb 2011 Pg. 56-61	Basics of Compounding: Basics of Compounding with Potency Designated Ingredients Author(s): Allen Loyd V Jr
Jan/Feb 2011 Pg. 64	Diclofenac Sodium 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2011 Pg. 65	Hydrocortisone Acetate 1% Gel, Alcohol-Free Author(s): Allen Loyd V Jr
Jan/Feb 2011 Pg. 66	Ibuprofen 5% Gel Author(s): Allen Loyd V Jr
Jan/Feb 2011 Pg. 67	Mandelic Acid 5% Cream Author(s): Allen Loyd V Jr
Jan/Feb 2011 Pg. 68	Methotrexate 30-mg/g Topical Gel Author(s): Allen Loyd V Jr
Jan/Feb 2011 Pg. 69	Piroxicam 1% Gel Author(s): Allen Loyd V Jr
Jan/Feb 2011 Pg. 70	Pramoxine 1% Cream Author(s): Allen Loyd V Jr
Jan/Feb 2011 Pg. 71	Sodium Nitroprusside and Sodium Thiosulfate Intravenous Admixture Author(s): Allen Loyd V Jr
Jan/Feb 2011 Pg. 72	Terbenafine Hydrochloride Bilayer Nail Lacquer Author(s): Allen Loyd V Jr
Jan/Feb 2011 Pg. 73	Vancomycin Hydrochloride 25-mg/mL Solution Author(s): Allen Loyd V Jr
Nov/Dec 2010 Pg. 508-510	Basics of Compounding: Basics of Compounding with Aliquots, Dilutions, and Concentrates Author(s): Allen Loyd V Jr
Nov/Dec 2010 Pg. 512	Amitriptyline Hydrochloride 2%, Baclofen 5%, Ketamine Hydrochloride 5%, Ketoprofen 10% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Nov/Dec 2010 Pg. 513	Baclofen 5%, Capcaicin 0.075%, Ketoprofen 10%, and Tetracaine 2% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Nov/Dec 2010 Pg. 514	Baclofen 5%, Gabapentin 5%, Ketoprofen 10%, and Lidocaine 5% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Nov/Dec 2010 Pg. 517	Capsaicin 0.05% Clear Medication Stick Author(s): Allen Loyd V Jr
Nov/Dec 2010 Pg. 518	Glutathione 25% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Nov/Dec 2010 Pg. 519	Gramicidin 13% Ophthalmic Solution Author(s): Allen Loyd V Jr
Nov/Dec 2010 Pg. 521	Ketoprofen 2% Oral Gel Author(s): Allen Loyd V Jr
Nov/Dec 2010 Pg. 448	PreScription: Compounding with Manufactured Products Author(s): Allen Loyd V Jr
Nov/Dec 2010 Pg. 515	Bromazepam 2.5-mg/mL Drops Author(s): Allen Loyd V Jr
Nov/Dec 2010 Pg. 516	Bromhexine Hydrochloride 0.8-mg/mL Syrup Author(s): Allen Loyd V Jr
Nov/Dec 2010 Pg. 520	Ketoprofen 5% and Lidocaine Hydrochloride 0.5% Topical Gel Author(s): Allen Loyd V Jr
Sep/Oct 2010 Pg. 358	PreScription: Revised Format Author(s): Allen Loyd V Jr
Sep/Oct 2010 Pg. 420	Alpha-Bisabolol Mouthwash Author(s): Allen Loyd V Jr
Sep/Oct 2010 Pg. 422	Icy Blue Camphorated Gel Author(s): Allen Loyd V Jr
Sep/Oct 2010 Pg. 423	Carvedilol 1-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2010 Pg. 416-418	Basics of Compounding: Basics of Compounding with Esters Author(s): Allen Loyd V Jr
Sep/Oct 2010 Pg. 424	Buspirone 2.5-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2010 Pg. 421	Three Fortified Ophthalmic Solutions: Amikacin 5% Ophthalmic Solution; Ceftazidime 5% Ophthalmic Solution; Vancomycin 5% Ophthalmic Solution Author(s): Allen Loyd V Jr
Sep/Oct 2010 Pg. 425	Triclosan 0.28% Mouthwash Author(s): Allen Loyd V Jr
Sep/Oct 2010 Pg. 426	Rufinamide 40-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2010 Pg. 427	Haloperidol 0.416-mg/mL, Hyoscine 4.9-mg/mL, and Tramadol 16.67-mg/mL in 0.9% Sodium Chloride Injection Author(s): Allen Loyd V Jr
Sep/Oct 2010 Pg. 428	Panitumumab 2.5-mg/mL in 0.9% Sodium Chloride Injection Author(s): Allen Loyd V Jr
Sep/Oct 2010 Pg. 429	Polidocanol 0.5% Wound Spray Author(s): Allen Loyd V Jr
Jul/Aug 2010 Pg. 268	PreScription: Beginning of a New United States Pharmacopeial Convention, Inc., Cycle Author(s): Allen Loyd V Jr
Jul/Aug 2010 Pg. 284-300	Hygrometers and Thermohygrometers: Environmental Monitoring Ensures the Potency and Stability of Compounding Agents Author(s): Allen Loyd V Jr, McKenzie Robert, Ainsworth Ron, Kastango Eric S, Kaestner Rick, Rebelo Andre, Burnside Paul, Schultz Gerald
Jul/Aug 2010 Pg. 332	Acyclovir with Benzocaine Lip Balm Author(s): Allen Loyd V Jr
Jul/Aug 2010 Pg. 333	Acyclovir 5% Lip Balm with Dioxybenzone and Oxybenzone Author(s): Allen Loyd V Jr
Jul/Aug 2010 Pg. 334	Amitriptyline Hydrochloride Suppositories Author(s): Allen Loyd V Jr
Jul/Aug 2010 Pg. 322-326	Basics of Compounding: Basics of Compounding with Organic Salts Author(s): Allen Loyd V Jr
Jul/Aug 2010 Pg. 328-331	Basics of Compounding: Considerations for Implementing USP Chapter <797> Pharmacy Compounding -- Sterile Preparations, Part 20: Patient or Caregiver Training, Patient Monitoring and Adverse Events Reporting, and Quality-Assurance Program Author(s): Okeke Claudia C, Allen Loyd V Jr
Jul/Aug 2010 Pg. 335	Ampicillin 250-mg Suppository Author(s): Allen Loyd V Jr
Jul/Aug 2010 Pg. 336	Antazoline Phosphate and Xylometazoline Hydrochloride Ophthalmic Drops Author(s): Allen Loyd V Jr
Jul/Aug 2010 Pg. 337	Buprenorphine Hydrochloride Injection Author(s): Allen Loyd V Jr
Jul/Aug 2010 Pg. 338	Chloroprocaine Hydrochloride Injection Author(s): Allen Loyd V Jr
Jul/Aug 2010 Pg. 339	Cyanocobalamin, Choline, and Niacinamide Injection Author(s): Allen Loyd V Jr
Jul/Aug 2010 Pg. 340	Fenoldopam Mesylate Injection Author(s): Allen Loyd V Jr
Jul/Aug 2010 Pg. 341	Flurbiprofen 5% Bioadhesive Gel for Gingivitis Author(s): Allen Loyd V Jr
May/Jun 2010 Pg. 180	PreScription: Quality Improvement in Pharmaceutical Compounding Author(s): Allen Loyd V Jr
May/Jun 2010 Pg. 240	Bacitracin 10,000-Units/mL Ophthalmic Solution Author(s): Allen Loyd V Jr
May/Jun 2010 Pg. 241	Carprofen 2.5-mg/mL Oral Suspension, Veterinary Author(s): Allen Loyd V Jr
May/Jun 2010 Pg. 242	Celecoxib 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2010 Pg. 222-229	Basics of Compounding: Compounding with Hydrates and Solvates Author(s): Allen Loyd V Jr
May/Jun 2010 Pg. 232-238	Basics of Compounding: Considerations for Implementing USP Chapter <797> -- Sterile Preparations, Part 19: Storage and Beyond-Use Dating, Maintaining Sterility, Purity, and Stability of Dispensed and Distributed Compounded Sterile Preparations Author(s): Okeke Claudia C, Allen Loyd V Jr
May/Jun 2010 Pg. 243	Clozapine 20-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2010 Pg. 244	Cohen's Rectal Ointment Author(s): Allen Loyd V Jr
May/Jun 2010 Pg. 245	Cyclophosphamide 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2010 Pg. 246	Lansoprazole 3-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2010 Pg. 247	Rifaximin 20-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2010 Pg. 248	Sunitinib 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2010 Pg. 249	Voriconazole 40-mg/mL Oral Suspension, Veterinary Author(s): Allen Loyd V Jr
Mar/Apr 2010 Pg. 92	PreScription: The Ages of Man Author(s): Allen Loyd V Jr
Mar/Apr 2010 Pg. 142-149	Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 18: Verification of Automated Compounding Devices for Parenteral Nutrition Compounding and Finished Preparation Release Checks and Tests Author(s): Allen Loyd V Jr, Okeke Claudia C